Authors
Loading...
Observational analysis shows that adding drug restriction notifications improves claim approval for outpatient chemotherapy, suggesting enhanced compliance with guidelines.
Nofiyanti et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: